Skip to content

Asset turnover at other companies

Eli Lilly logo
Eli LillyLLY
0.7×+0.1×
Arrowhead Research logo
Arrowhead ResearchARWR
0.3×-0.1×

Other financials

Income statement

See full
Revenue$311.3M+127%
Gross profit$43.5M
Operating income-$92.7M-16.9%
Net income-$94.4M-28.9%
EPS (diluted)-$3.25-24.5%

Balance sheet

See full
Cash & equivalents$232.2M+23.1%
Total debt$377.3M+187%
Total equity$543.5M-23.5%
Total assets$1.2B+23.1%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$3.8M
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.66B+64.2%
Enterprise value$11.81B+67.5%
P/S10.3×-12.1×

Profitability

See full
Gross margin96.5%
Operating margin-27.7%-12.2pp
Net margin-27.3%-12.0pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-49.3%-0.8pp
Debt / equity0.7×+0.5×
Current ratio3.5×-2.4×

Where this comes from

Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madrigal Pharmaceuticals, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Madrigal Pharmaceuticals, Inc.'s asset turnover?
Madrigal Pharmaceuticals, Inc. (MDGL) reported asset turnover of 1× in Q1 2026.
How has Madrigal Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
Madrigal Pharmaceuticals, Inc.'s asset turnover increased by 233.6% year-over-year, from 0.3× to 1×.
What does asset turnover mean?
How many sales dollars the company generates from each dollar of assets.
How do you interpret asset turnover?
Higher turnover means a more sales-efficient asset base. Low-margin businesses (retail, distribution) compete on high turnover; high-margin ones (software, luxury) on margin.
How does asset turnover compare across companies?
Compare within an industry — turnover differences across sectors reflect business models, not performance.